Atherosclerotic Disease
Atherosclerotic Disease
Advertisement
Rob DillardAtherosclerotic Disease | April 17, 2025
Researchers have developed a polygenic risk score to analyze the link between dysfunctional endothelial and CAD.
Read More
Jordana JampelAtherosclerotic Disease | April 17, 2025
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
Rob DillardCardiology | April 17, 2025
The FDA recently announced a first time proposed rule which would require the tobacco industry to lower nicotine levels.
Jordana JampelAtherosclerotic Disease | April 17, 2025
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
Rob DillardLipid Management | April 17, 2025
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
Rob DillardAtherosclerotic Disease | April 17, 2025
Higher lipoprotein(a) levels are associated with an increased progression of coronary plaque burden.
Rob DillardAtherosclerotic Disease | April 17, 2025
Researchers developed an at-home questionnaire test that quickly identifies people at high risk of heart attack.
Rob DillardACC 2024 | April 17, 2025
People with heart disease could benefit from a low-sodium diet but, on average, consume twice the recommended amount of salt.
Rob DillardLipid Management | April 17, 2025
US veterans have a disproportionately high risk of atherosclerotic cardiovascular disease and a low adherence to LLT.
Rob DillardACC 2024 | April 17, 2025
Older firefighters may have more thrombotic risk factors that contribute to a higher risk of coronary heart disease.
Rob DillardLipid Management | April 17, 2025
Distinct variations of coronary artery calcium-derived coronary artery heart disease exist among retired NFL players.
Rob DillardACC 2024 | April 17, 2025
A remote, algorithm-based program is effective at helping patients achieve optimal LDL-C levels for at least 12 months.
Dr. Marc BonacaCardiology | April 17, 2025
Dr. Marc Bonaca discusses the VOYAGER PAD study, which showed the efficacy of rivaroxaban in lower extremity PAD.
Dr. Eugenia AllevaAHA 2023 | April 17, 2025
Dr. Eugenia Alleva discusses a study that found women with dysmenorrhea have increased cardiovascular risk.
Dr. Ijeoma EleazuAHA 2023 | April 17, 2025
Dr. Ijeoma Eleazu talks about the harmful impact of cumulative stress on cardiovascular health.
Dr. James MinAHA 2023 | April 17, 2025
James K. Min, MD, founder and CEO of Cleerly, talks about improved screening for heart disease using a digital care platform.
Rob DillardAHA 2023 | April 17, 2025
Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores.
Rob DillardTCT 2023 | April 17, 2025
Researchers analyzed the long-term impact of TAVR on coronary arteries and cardiac hemodynamics.
Rob DillardAtherosclerotic Disease | October 16, 2023
A cardio-oncology rehabilitation program can benefit cancer survivors at high risk of cardiovascular disease.
CardioNerdsCardioNerds | April 17, 2025
The CardioNerds correspondents Drs. Amo-Tweneboah and Nedadur preview the CLE Care of Aortic Disease Symposium.
Advertisement
Advertisement